APA (7th ed.) Citation

Moreau-Bachelard, C., Campion, L., Robert, M., Kerdraon, O., Renaudeau, C., Aumont, M., . . . Frénel, J. (2020). Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients. MDPI AG.

Chicago Style (17th ed.) Citation

Moreau-Bachelard, Camille, Loïc Campion, Marie Robert, Olivier Kerdraon, Céline Renaudeau, Maud Aumont, Jean-Marc Classe, Mario Campone, and Jean-Sébastien Frénel. Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for Up to Ten Years in Postmenopausal Early Breast Cancer Patients. MDPI AG, 2020.

MLA (8th ed.) Citation

Moreau-Bachelard, Camille, et al. Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for Up to Ten Years in Postmenopausal Early Breast Cancer Patients. MDPI AG, 2020.